Ganciclovir, a regular medicine used to treat human cytomegalovirus (HCMV) infections, was found less efficient when reacting to human’s NUDT15 enzyme — based on a recent BioMAX study. This finding…
…and at MAX IV we strive to meet the experimental needs of our ever -expanding and -evolving community. LDM-relevant beamline We offer access to a number of LDM-relevant beamlines (highlighted…
…availability for beamtime and complex, unfamiliar methods of data analysis for new users, among others. The current study demonstrates the exciting possibilities of X-ray measurements at lightsources like MAX IV….
…for your research! Start your user journey with us by learning more about what to do in preparation for your final application. Click the “Full overview” button for the complete…
…value for their business. The day will also include presentations from institutes, companies, academic centers and other organizations that help industry get access to, or make use of, analytic tools…
…in the first Recruitment Call of Doctoral Students. 13 additional research projects have been chosen following below described selection process. Those research projects will be offered in the second Recruitment…
MAX IV operates 16 beamlines with an opportunity to add more in the future. The beamlines are situated on our 1.5 GeV (R1) or 3 GeV (R3) storage rings or…
…policy pages for the formal statement. Björling et al., Optics Express (2020), for the coherent nanofocused beam. Johansson et al., Journal of Synchrotron Radiation (2021), for the beamline instrumentation and…
…2018 Initial Operation of the NanoMAX Beamline at MAX IV 10.1017/S1431927618013600 Describes the beamline early performance right up to start of regular user operation. 2017 First x-ray nanoimaging experiments at…
…the elusive Fischer-Tropsch reaction “The mechanism of the Fischer-Tropsch reaction in which synthesis gas is converted into long-chain hydrocarbons is very complex and continues to be debated”, explains Dr. Kees-Jan Weststrate,…